Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab plus leflunomide in active rheumatoid arthritis
2005-004582-41Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Jan 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rituximab and leflunomide in rheumatoid arthritis (RA), sponsored by University of Leeds. Primary endpoints: Disease Activity Score 28 (DAS28) and Safety (adverse events and laboratory monitoring). Started Jan 2006; status: completed.
02
Drugs
rituximableflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-004582-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004582-41.